People News: Biogen Idec, Noven Pharmaceuticals and Corbett Accel
James Mullen, president and CEO of Biogen Idec, will retire from his position effective June 8, the company said. Mullen ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.